发明名称 MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION
摘要 The present invention provides compositions and methods for modulating the expression of growth factor gene. In particular, this invention relates to compounds, particularly oligonucleotide compounds, which, in preferred embodiments, hybridize with nucleic acid molecules encoding the Insulin Like Growth Factor I receptor (IGF-I receptor or IGF-IR) and in particular human IGF-IR. Such compounds are exemplified herein to modulate proliferation which is relevant to the treatment of proliferative and inflammatory skin disorders and cancer. It will be understood, however, that the compounds can be used for any other condition in which the IGF-IR is involved including inflammatory condition.
申请公布号 US2013096176(A1) 申请公布日期 2013.04.18
申请号 US201213493827 申请日期 2012.06.11
申请人 WRAIGHT CHRISTOPHER JOHN;WERTHER GEORGE ARTHUR;DEAN NICHOLAS M.;DOBIE KENNETH W.;ANTISENSE THERAPEUTICS LIMITED 发明人 WRAIGHT CHRISTOPHER JOHN;WERTHER GEORGE ARTHUR;DEAN NICHOLAS M.;DOBIE KENNETH W.
分类号 C07H21/04;A61K38/00;A61P17/00;A61P35/00;C07H21/00;C07H21/02;C12N15/113;C12N15/12;C12Q1/68 主分类号 C07H21/04
代理机构 代理人
主权项
地址